Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 26, 2005The Journal of Clinical Pharmacology

Pharmacokinetics of Long‐Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

RTRyan Z. TurncliffNew York Medical CollegeJDJoi DunbarSage Therapeutics (United States)QDQunming DongBiogen (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Turncliff et al. (2005) studied this question.

synapsesocial.com/papers/6a9e67618dd5fc7fdbd70624https://doi.org/10.1177/0091270005280199
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence2005 · 635 citations
  2. 2Kinetics and inhibition of the formation of 6β‐naltrexol from naltrexone in human liver cytosol2000 · 64 citations
  3. 3Patients with Alcohol Problems1998 · 273 citations
  4. 4The Effect of Liver Cirrhosis on the Regulation and Expression of Drug Metabolizing Enzymes2004 · 139 citations